Showing results (41-50 of 672) with videos related to
Sort By:
Pageof 68
Neuropharmacology|July 1, 1995
Therapeutic brain concentration of the NMDA receptor antagonist amantadineJ Kornhuber, G Quack, W Danysz, et al.Annals of Neurology|May 1, 1986
Dopamine D2 receptor density remains constant in treated Parkinson's diseaseM Guttman, P Seeman, G P Reynolds, et al.Biological Psychiatry|July 1, 1994
Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patientsJ Kornhuber, K W Lange, P Kruzik, et al.Journal of Neurochemistry|September 1, 1992
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysisK Jellinger, E Kienzl, G Rumpelmair, et al.Journal of Neural Transmission. Supplementum|January 1, 1990
Reflection of changes in membrane constituents in various regions of Alzheimer brains to differential scanning thermogramsE Sofic, M Götz, L Frölich, et al.Brain Research|November 25, 1996
A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndromeM Gerlach, W Gsell, J Kornhuber, et al.Journal of Neural Transmission. Supplementum|January 1, 1990
Urinary dopamine sulfate: regulations and significance in neurological disordersE Kienzl, K Eichinger, E Sofic, et al.Journal of Neural Transmission. Supplementum|April 24, 2007
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseasesE Sofic, A Sapcanin, I Tahirovic, et al.Journal of Neurochemistry|February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brainsP Riederer, E Sofic, W D Rausch, et al.Science (New York, N.Y.)|August 17, 1984
Bimodal distribution of dopamine receptor densities in brains of schizophrenicsP Seeman, C Ulpian, C Bergeron, et al.Pageof 68